Li C - Search Results

1

Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study.

Wu J, Li C, Gao P, Zhang C, Zhang P, Zhang L, Dai C, Zhang K, Shi B, Liu M, Zheng J, Pan B, Chen Z, Zhang C, Liao W, Pan W, Fang W, Chen C. Wu J, et al. Among authors: li c. Signal Transduct Target Ther. 2023 Sep 1;8(1):326. doi: 10.1038/s41392-023-01515-3. Signal Transduct Target Ther. 2023. PMID: 37652953 Free PMC article.

2

Improvement of surgical techniques for orthotopic single lung transplantation in rats.

Gao P, Li C, Ning Y, Wu J, Zhang P, Liu X, Su Y, Zhao D, Chen C. Gao P, et al. Among authors: li c. Ann Transl Med. 2022 Jun;10(12):673. doi: 10.21037/atm-22-2018. Ann Transl Med. 2022. PMID: 35845494 Free PMC article.

3

The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study.

Li C, Wu J, Jiang L, Zhang L, Huang J, Tian Y, Zhao Y, Liu X, Xia L, E H, Gao P, Hou L, Yang M, Ma M, Su C, Zhang H, Chen H, She Y, Xie D, Luo Q, Chen C. Li C, et al. Cancer Immunol Immunother. 2023 Mar;72(3):783-794. doi: 10.1007/s00262-022-03262-w. Epub 2022 Sep 3. Cancer Immunol Immunother. 2023. PMID: 36056951 Free PMC article.

4

Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study.

Li C, Wu J, Jiang L, Zhang L, Huang J, Tian Y, Zhao Y, Liu X, Xia L, E H, Gao P, Hou L, Yang M, Ma M, Su C, Zhang H, Chen H, She Y, Xie D, Luo Q, Chen C. Li C, et al. Cancer Immunol Immunother. 2023 Mar;72(3):795. doi: 10.1007/s00262-022-03294-2. Cancer Immunol Immunother. 2023. PMID: 36125538 Free PMC article. No abstract available.

5

The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma.

Li K, Wu LL, Wang H, Cheng H, Zhuo HM, Hao Y, Liu ZY, Li CW, Qian JY, Li ZX, Xie D, Chen C. Li K, et al. Among authors: li zx, li cw. Front Oncol. 2022 Nov 25;12:1011568. doi: 10.3389/fonc.2022.1011568. eCollection 2022. Front Oncol. 2022. PMID: 36505852 Free PMC article.

6

Establishment of a risk prediction model for prolonged mechanical ventilation after lung transplantation: a retrospective cohort study.

Gao P, Li C, Wu J, Zhang P, Liu X, Li Y, Ding J, Su Y, Zhu Y, He W, Ning Y, Chen C. Gao P, et al. Among authors: li c, li y. BMC Pulm Med. 2023 Jan 10;23(1):11. doi: 10.1186/s12890-023-02307-9. BMC Pulm Med. 2023. PMID: 36627599 Free PMC article.

7

The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy.

E H, Wu J, Ren Y, Xia L, Xu L, Li S, Zhao Y, Li C, She Y, Su C, Wu C, Hou L, Zhao D, Chen C. E H, et al. Among authors: li s, li c. Ther Adv Med Oncol. 2023 Jan 10;15:17588359221148028. doi: 10.1177/17588359221148028. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36643658 Free PMC article.

8

Utility of ¹⁸F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.

Zhuang F, Haoran E, Huang J, Wu J, Xu L, Zhang L, Li Q, Li C, Zhao Y, Yang M, Ma M, She Y, Chen H, Luo Q, Zhao D, Chen C. Zhuang F, et al. Among authors: li c, li q. Lung Cancer. 2023 Apr;178:20-27. doi: 10.1016/j.lungcan.2023.02.001. Epub 2023 Feb 3. Lung Cancer. 2023. PMID: 36764154

9

Clinical utility of [¹⁸F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancer.

Zhang L, E H, Huang J, Wu J, Li Q, Hou L, Li C, Dai C, Deng J, Yang M, Ma M, Ren Y, Luo Q, Zhao D, Chen C. Zhang L, et al. Among authors: li c, li q. Eur Radiol. 2023 Dec;33(12):8564-8572. doi: 10.1007/s00330-023-09910-8. Epub 2023 Jul 18. Eur Radiol. 2023. PMID: 37464112

10

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer.

Guo J, Zhang L, Zhang L, Wu J, Xu L, E H, Li C, Wu H, Zhao D, Hu Y, Zhang J, Hu X. Guo J, et al. Among authors: li c. J Cancer Res Clin Oncol. 2023 Nov;149(14):13311-13321. doi: 10.1007/s00432-023-05101-6. Epub 2023 Jul 24. J Cancer Res Clin Oncol. 2023. PMID: 37488397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,289 results

Search Page